scholarly journals TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLIMEPIRIDE AND METFORMIN BITHERAPY IN REAL CLINICAL PRACTICE IN THE GULF REGION: PATTERNS OF USE AND GLYCAEMIC CONTROL.

2018 ◽  
Vol 6 (3) ◽  
pp. 782-790
Author(s):  
Reyaz Ahmed ◽  
◽  
SameerMohammedAl Shammari ◽  
Leena Kapoor ◽  
Ahmed Mansour ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Practice ◽  
Glycaemic Control ◽  
Gulf Region ◽  
Patterns Of Use ◽  
Real Clinical Practice

The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience

Pharmateca ◽  
2020 ◽  
Vol 12_2020 ◽  
pp. 107-111
Author(s):  
L.Yu. Khamnueva Khamnueva ◽  
L.S. Andreeva Andreeva ◽  
A.V. Davydova Davydova ◽  
E.V. Chugunova Chugunova ◽  
N.P. Tokareva Tokareva ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Practice ◽  
Insulin Glargine ◽  
Clinical Experience ◽  
Fixed Ratio ◽  
Real Clinical Practice

Sodium–glucose cotransporter-2 inhibitors: where and when?

2021 ◽  
Author(s):  
Martin R Cowie
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Kidney Disease ◽  
Glycaemic Control ◽  
Improve Outcome ◽  
Is Implementation ◽  
Sodium Glucose Cotransporter

Tweetable abstract Sodium–glucose cotransporter-2 inhibitors not only improve glycaemic control in Type 2 diabetes mellitus but convincingly improve outcome for everyone with HFrEF and albuminuric kidney disease. Trials then license – now all we need is implementation

Sign in / Sign up

Export Citation Format

Share Document